Potassium Acetate → 5-(5,7-Difluoro-3-methyl-2-(pyridin-2-yl)quinolin-4-ylamino)-6-morpholinopyridin-3-ylboronic acid

HRID 1431306Notizen

Reaktionsgleichung

Br[C:2]1[CH:3]=[C:4]([NH:14][C:15]2[C:24]3[C:19](=[CH:20][C:21]([F:26])=[CH:22][C:23]=3[F:25])[N:18]=[C:17]([C:27]3[CH:32]=[CH:31][CH:30]=[CH:29][N:28]=3)[C:16]=2[CH3:33])[C:5]([N:8]2[CH2:13][CH2:12][O:11][CH2:10][CH2:9]2)=[N:6][CH:7]=1.CC1(C)C(C)(C)[O:38][B:37](B2OC(C)(C)C(C)(C)O2)[O:36]1.C([O-])(=O)C.[K+]>C1CCC(P(C2CCCCC2)C2CCCCC2)CC1.C1CCC(P(C2CCCCC2)C2CCCCC2)CC1.[Pd].O1CCOCC1>[F:25][C:23]1[CH:22]=[C:21]([F:26])[CH:20]=[C:19]2[C:24]=1[C:15]([NH:14][C:4]1[CH:3]=[C:2]([B:37]([OH:38])[OH:36])[CH:7]=[N:6][C:5]=1[N:8]1[CH2:13][CH2:12][O:11][CH2:10][CH2:9]1)=[C:16]([CH3:33])[C:17]([C:27]1[CH:32]=[CH:31][CH:30]=[CH:29][N:28]=1)=[N:18]2

Komponenten

Reaktionsbedingungen

Temperatur: 93 °C

Versuchsvorschrift

A solution of N-(5-bromo-2-morpholinopyridin-3-yl)-5,7-difluoro-3-methyl-2-(pyridin-2-yl)quinolin-4-amine (395 mg, 0.77 mmol; described herein), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (215 mg, 0.85 mmol), bis(tricyclohexylphosphine)palladium(o) (25.7 mg, 0.039 mmol), potassium acetate (113 mg, 1.16 mmol), and 1,4-dioxane (10.6 mL) was stirred at 93° C. for 24 h. The reaction was then cooled to rt and partitioned between EtOAc and water. The organic layer was dried (magnesium sulfate) and concentrated, and chromatography afforded 5-(5,7-difluoro-3-methyl-2-(pyridin-2-yl)quinolin-4-ylamino)-6-morpholinopyridin-3-ylboronic acid as a yellow solid. Mass Spectrum (ESI) m/e=478.1 (M+1).

Aufarbeitung

temperatureThe reaction was then cooled to rt
custompartitioned between EtOAc and water
dry with materialThe organic layer was dried (magnesium sulfate)
concentrationconcentrated

Quellen und Nachweise

ORD-Eintrag: ord-8cd206e51e1a44c8a2e5b31e15420eef
Quelldatensatz: uspto-grants-2015_01
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US08940724B2

Notizen zur Reaktion

Wird geladen…